News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: AnteoTech initiates TGA submission, Zelira jumps 10pc after launching CBD-based acne gel
News
10 at 10: These ASX stocks have grown surprisingly big this morning
Health & Biotech
ScoPo’s Powerplays: As focus turns to Delta variant, these ASX health stocks are profiting from COVID-19 testing
Health & Biotech
Check Up: ASX biotech comes alive as health stocks tackle international markets
Health & Biotech
ASX Health Stocks: Cannabis play Cronos scoots 19% higher on merger news, Telix gets FDA nod for clinical trial
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
ASX Health Stocks: HeraMed jumps 11pc on survey results, while Acrux seeks FDA approval for acne gel
IPO Watch
IPO Watch: Clarity Pharmaceuticals joins the ASX after completing $92m IPO
Health & Biotech
ScoPo’s Powerplays: Quality names continue to catch a bid as earnings roll in
Health & Biotech
ASX Health Stocks: NeuroScientific soars 10pc on COVID-19 drug, Telix advances prostate cancer studies
News
Closing Bell: ASX retreats for the third day in a row
News
Here are the top ASX large cap movers for Wednesday
Health & Biotech
ASX health stocks: CSL leads another round of strong earnings, but FY22 outlook remains subdued
Health & Biotech
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress
Health & Biotech
ASX Health Stocks: Osprey jumps 8% on solid first half; Bard1 concludes successful study
Health & Biotech
Australian biotech figurehead Paul Hopper raises $20 million for his latest pre-IPO venture
News